輸入代號或公司名稱後按 Enter
4163

鐿鈦

-0.50 (-0.39%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
128.5049成交張數21.82本益比2.41股價淨值比2.72%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q21.66453.3%6.110.8111.9%3.05%11.42%
2026Q11.29-22.8%4.750.6310.2%2.38%9.01%
2025Q41.577.5%5.130.7713.2%2.87%9.38%
2025Q31.5974.7%5.020.7712.8%3.02%9.45%
2025Q20.30-75.8%4.340.152.4%0.58%8.40%
2025Q11.67-5.7%5.280.8113.3%3.15%9.99%
2024Q41.46329.4%5.380.7012.2%2.74%10.24%
2024Q30.91-58.5%4.260.447.5%1.75%8.25%
2024Q21.24-38.3%5.540.609.9%2.36%11.09%
2024Q11.77-29.5%6.310.8614.2%3.40%12.31%
2023Q40.34-70.2%7.050.172.9%0.68%14.42%
2023Q32.19-43.6%7.851.0618.0%4.41%16.29%
2023Q22.010.5%9.540.9715.9%4.11%21.26%
2023Q12.5145.1%9.531.2118.3%5.25%20.97%
2022Q41.14-23.5%8.750.558.3%2.46%20.21%
2022Q33.88152.0%9.101.8827.9%8.95%21.67%
2022Q22.00150.0%6.760.9617.0%4.80%16.49%
2022Q11.7392.2%5.560.8416.3%4.25%13.65%
2021Q41.49106.9%4.730.7214.2%3.81%12.07%
2021Q31.5434.1%3.960.7415.0%3.87%10.30%
2021Q20.80-48.1%3.570.397.5%2.00%9.20%
2021Q10.90-47.1%4.310.439.6%2.30%10.83%
2020Q40.72-21.5%5.110.357.2%1.87%13.35%
2020Q31.15-41.1%5.310.5611.0%3.05%14.08%
2020Q21.54-49.0%6.110.7416.0%4.01%16.88%
2020Q11.703.0%7.590.8216.2%4.37%20.17%
2019Q40.92-41.5%7.540.448.4%2.43%20.97%
2019Q31.9521.3%8.190.9416.2%5.38%23.60%
2019Q23.0341.2%7.851.4619.9%8.57%23.84%
2019Q11.65127.6%6.970.8016.4%4.77%21.19%
2018Q41.57113.6%6.040.7615.3%4.76%19.04%
2018Q31.6139.9%5.210.7715.0%5.09%16.95%
2018Q22.14140.2%4.751.0422.1%7.03%16.21%
2018Q10.7397.7%3.500.358.2%2.41%11.20%
2017Q40.73-57.9%3.140.358.2%2.49%10.21%
2017Q31.15-16.9%4.150.5611.4%4.03%13.98%
2017Q20.89-65.7%4.380.439.5%2.96%15.40%
2017Q10.37-76.6%6.090.184.0%1.15%19.61%
2016Q41.747.290.8418.2%5.61%
2016Q31.380.6713.2%4.68%